Skip to main content
. 2022 Jun 6;2022:1972516. doi: 10.1155/2022/1972516

Figure 3.

Figure 3

Analysis of progression-free survival and overall survival of melanoma patients with different levels of AGAP2-AS1 using TCGA database and KM survival curve.